These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20130475)

  • 1. Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.
    Lin RJ; Curran JJ; Zimmerman TM; Song J; Niewold TB; Sweiss NJ
    J Clin Rheumatol; 2010 Mar; 16(2):90-1. PubMed ID: 20130475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma].
    Taniguchi H; Imaizumi Y; Makiyama J; Ando K; Sawayama Y; Imanishi D; Taguchi J; Tsushima H; Hata T; Miyazaki Y
    Rinsho Ketsueki; 2014 Aug; 55(8):953-7. PubMed ID: 25186485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma.
    Nakamura N; Kanemura N; Shibata Y; Matsumoto T; Mabuchi R; Nakamura H; Kitagawa J; Goto N; Hara T; Tsurumi H; Moriwaki H
    Leuk Lymphoma; 2014 Jul; 55(7):1691-3. PubMed ID: 24138307
    [No Abstract]   [Full Text] [Related]  

  • 4. Lenalidomide in renal insufficiency--balancing the risks and benefits.
    Borrello I
    Br J Haematol; 2009 Feb; 144(3):446-7; author reply 447-8. PubMed ID: 19120361
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide.
    Morita Y; Shimada T; Yamaguchi T; Rai S; Hirase C; Emoto M; Serizawa K; Taniguchi Y; Ojima M; Tatsumi Y; Ashida T; Matsumura I
    Int J Hematol; 2011 Dec; 94(6):583-4. PubMed ID: 22127558
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.
    García-Muñoz R; Robles-de-Castro D; Muñoz-Rodríguez A; Rabasa P
    Leuk Lymphoma; 2013 Dec; 54(12):2753-5. PubMed ID: 23488662
    [No Abstract]   [Full Text] [Related]  

  • 7. Type 1 cryoglobulinemia: response to thalidomide and lenalidomide.
    Calabrese C; Faiman B; Martin D; Reu F; Calabrese LH
    J Clin Rheumatol; 2011 Apr; 17(3):145-7. PubMed ID: 21441816
    [No Abstract]   [Full Text] [Related]  

  • 8. Desensitization to lenalidomide in a patient with relapsed multiple myeloma.
    Seki JT; Banglawala S; Lentz EM; Reece DE
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):162-5. PubMed ID: 23103087
    [No Abstract]   [Full Text] [Related]  

  • 9. Lenalidomide in multiple myeloma.
    Thomas SK; Richards TA; Weber DM
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):717-35. PubMed ID: 18070715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse alveolar hemorrhage associated with lenalidomide.
    Sakai M; Kubota T; Kuwayama Y; Ikezoe T; Yokoyama A
    Int J Hematol; 2011 Jun; 93(6):830-831. PubMed ID: 21573890
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma in the United States of America: A population-based cohort study.
    Luo J; Gagne JJ; Landon J; Avorn J; Kesselheim AS
    Eur J Cancer; 2017 Jan; 70():22-33. PubMed ID: 27866096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.
    Laubach JP; Schlossman RL; Mitsiades CS; Anderson KC; Richardson PG
    Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma.
    Cem Ar M; Soysal T; Hatemi G; Salihoglu A; Yazici H; Ulku B
    Ann Hematol; 2005 Sep; 84(9):609-13. PubMed ID: 15906029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide for the treatment of relapsed multiple myeloma.
    Gajraj E; Chung H; Boysen M; Barnett DB; Longson C
    Lancet Oncol; 2009 Jul; 10(7):647-8. PubMed ID: 19585686
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of lenalidomide in the treatment of multiple myeloma].
    Holánek M; Hájek R
    Klin Onkol; 2010; 23(2):67-72. PubMed ID: 20465083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone.
    Montagnese F; Portaro S; Musumeci O; Migliorato A; Moggio M; Fagiolari G; Rodolico C
    Muscle Nerve; 2015 Jun; 51(6):934-5. PubMed ID: 25524603
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of patients with multiple myeloma and impaired renal function with lenalidomide: results of 4 German centers.
    Oehrlein K; Langer C; Sturm I; Pönisch W; Hahn-Ast C; Kuhn S; Weisel KC
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):191-6. PubMed ID: 22341857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenalidomide and its role in the management of multiple myeloma.
    Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal ischemic stroke in a patient receiving lenalidomide for multiple myeloma.
    Tannemaat MR; Vries EP; Molendijk WJ; Haan J
    Clin Neurol Neurosurg; 2011 Jul; 113(6):488-9. PubMed ID: 21315504
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide.
    Mariz JM; Esteves GV
    Curr Opin Oncol; 2012 Jan; 24 Suppl 2():S3-11. PubMed ID: 22245806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.